About: Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial as an early intervention for maintaining the health and integrity of retinal tissues in stargardt disease type 1 and geographic atrophy patients. The company also develops LBS-009, an retinol binding protein 4 oral therapy, which is in preclinical development targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, as well as gout. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.
Sector: Healthcare
Industry: Biotechnology
Latest price: $150.50 (+0.15%)
BLTE NASDAQ Belite Bio Inc ADR
Belite Bio Inc ADR share price
BLTE price activity
Last Price
$150.500
Change (24hr)
0.22 USD (0.15%)
Volume
43.94K
Volume (4w avg)
-
Open
$148.79
Day Range
$146.90 - $150.77
Previous Close
$150.28
Last Trade
30 Oct, 3:45 pm GMT+0
Delayed
30 Oct, 3:45 pm GMT+0
BLTE price performance
Delayed
30 Oct, 3:45 pm GMT+0
BLTE Market Signals